JP2014517694A5 - - Google Patents

Download PDF

Info

Publication number
JP2014517694A5
JP2014517694A5 JP2014512189A JP2014512189A JP2014517694A5 JP 2014517694 A5 JP2014517694 A5 JP 2014517694A5 JP 2014512189 A JP2014512189 A JP 2014512189A JP 2014512189 A JP2014512189 A JP 2014512189A JP 2014517694 A5 JP2014517694 A5 JP 2014517694A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
nucleic acid
acid sequence
vector
viral vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014512189A
Other languages
English (en)
Japanese (ja)
Other versions
JP6162104B2 (ja
JP2014517694A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/039897 external-priority patent/WO2012162705A2/en
Publication of JP2014517694A publication Critical patent/JP2014517694A/ja
Publication of JP2014517694A5 publication Critical patent/JP2014517694A5/ja
Application granted granted Critical
Publication of JP6162104B2 publication Critical patent/JP6162104B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014512189A 2011-05-26 2012-05-29 細胞及び遺伝子に基づく心臓機能改善方法 Active JP6162104B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161490450P 2011-05-26 2011-05-26
US61/490,450 2011-05-26
PCT/US2012/039897 WO2012162705A2 (en) 2011-05-26 2012-05-29 Cell and gene based methods to improve cardiac function

Publications (3)

Publication Number Publication Date
JP2014517694A JP2014517694A (ja) 2014-07-24
JP2014517694A5 true JP2014517694A5 (https=) 2015-07-16
JP6162104B2 JP6162104B2 (ja) 2017-07-12

Family

ID=47218136

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014512189A Active JP6162104B2 (ja) 2011-05-26 2012-05-29 細胞及び遺伝子に基づく心臓機能改善方法

Country Status (10)

Country Link
US (1) US9868937B2 (https=)
EP (1) EP2714709B1 (https=)
JP (1) JP6162104B2 (https=)
KR (1) KR20140035967A (https=)
CN (1) CN103946230B (https=)
AU (1) AU2012258525B2 (https=)
BR (1) BR112013030209A2 (https=)
CA (1) CA2837322C (https=)
RU (1) RU2608957C2 (https=)
WO (1) WO2012162705A2 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2714709B1 (en) 2011-05-26 2018-04-18 University of Washington Compositions for use in cell and gene based methods to improve cardiac function
EP2792742A1 (en) 2013-04-17 2014-10-22 Universitätsklinikum Hamburg-Eppendorf (UKE) Gene-therapy vectors for treating cardiomyopathy
WO2015153357A1 (en) * 2014-03-29 2015-10-08 Beat Biotherapeutics Corp. Compositions and methods for improving cardiac function
JP6832280B2 (ja) * 2015-01-16 2021-02-24 ユニバーシティ オブ ワシントンＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｗａｓｈｉｎｇｔｏｎ 新規のマイクロジストロフィンおよび使用の関連する方法
EP3268481B1 (en) * 2015-03-11 2020-05-27 The United States of America, as represented by The Secretary, Department of Health and Human Services Rpgr vectors for treating x-linked retinitis pigmentosa
EP3337892A2 (en) 2015-08-18 2018-06-27 Boston Scientific Scimed Inc. Methods for producing cardiomyocyte cells
JP6940920B2 (ja) 2017-02-04 2021-09-29 アナバイオス コーポレーション 医薬誘発性の変力作用および不整脈誘発のリスクを予測するためのシステムおよび方法
CN108913655B (zh) * 2018-07-16 2022-07-15 浙江大学 基于多能干细胞技术建立“人源性”心肌肥大模型的方法
CN119264211A (zh) 2018-08-27 2025-01-07 瑞泽恩制药公司 拉曼光谱在下游纯化中的应用
JP7450945B2 (ja) 2018-08-30 2024-03-18 テナヤ セラピューティクス， インコーポレイテッド ミオカルディンおよびａｓｃｌ１を用いた心細胞リプログラミング
US20200405824A1 (en) * 2019-06-26 2020-12-31 University Of Washington Use of ribonucleotide reductase alone or in combination with micro-dystrophin to treat duchenne muscular dystrophy striated muscle disease
CN110384800B (zh) * 2019-07-19 2021-06-08 广东省实验动物监测所 LncRNA XLOC_075168在制备促进血管新生的药物中的应用
EP4103214B1 (en) 2020-02-13 2026-04-29 Tenaya Therapeutics, Inc. Gene therapy vectors for treating heart disease
EP4319775A4 (en) * 2021-04-06 2025-03-05 University of Washington NON-CONTRACTILE CARDIOMYOCYTES FOR HEART REPAIR
EP4444893A4 (en) * 2021-12-10 2026-02-25 Spacecraft Seven Llc GENE THERAPY FOR TROPONIN C (TNNC1) USING AN AAV VECTOR
WO2025207745A1 (en) * 2024-03-27 2025-10-02 The Board Of Trustees Of The Leland Stanford Junior University Methods of inducing dilated cardiomyopathy phenotype in cardiomyocytes and applications thereof
CN120758566B (zh) * 2025-09-10 2025-11-21 瓯江实验室 一种在心肌细胞中特异性过表达zer1的病毒载体的构建及在心衰治疗中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02240440A (ja) 1989-03-14 1990-09-25 Shiigeru:Kk 慣性ダンパ
GB9022543D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Antibody production
US6151525A (en) * 1997-11-07 2000-11-21 Medtronic, Inc. Method and system for myocardial identifier repair
EP1085910A2 (en) * 1998-05-30 2001-03-28 Collateral Therapeutics, Inc. Methods of altering cardiac cell phenotype
AU5819599A (en) * 1998-09-11 2000-04-03 Regents Of The University Of California, The Recombinant adenovirus for tissue specific expression in heart
EP1139751A4 (en) * 1998-12-28 2003-03-19 Arch Dev Corp EFFICIENT AND STABLE -I (IN VIVO) GENE TRANSFER TO CARDIOMYCETS USING RECOMBINANT ADENO-ASSOCIATED VIRUS VECTORS
WO2002049714A2 (en) * 2000-12-21 2002-06-27 Medtronic, Inc. Electrically responsive promoter system
US20060002898A1 (en) * 2002-05-08 2006-01-05 Lee Randall J Methods and compositions for correction of cardiac conduction disturbances
AU2003270544A1 (en) 2002-09-11 2004-04-30 University Of Florida Vigilant vector system
US20070238675A1 (en) * 2003-08-11 2007-10-11 Phillips M I Stem Cell Beacon
US20070009496A1 (en) * 2003-11-21 2007-01-11 Daiichi Asubio Pharma Co., Ltd. Method of growing myocardial cells
WO2005094485A2 (en) * 2004-03-25 2005-10-13 Yun Yen Drug screening
DE102011018586A1 (de) 2011-04-26 2012-10-31 Oliver Müller Vektorsystem zur spezifischen Genexpression im Herzmuskel
EP2714709B1 (en) 2011-05-26 2018-04-18 University of Washington Compositions for use in cell and gene based methods to improve cardiac function

Similar Documents

Publication Publication Date Title
JP2014517694A5 (https=)
CL2019002280A1 (es) Vectores virales, adenovirales y composiciones a base de una secuencia de ornitina transcarbamilasa humana (hotch) modificada genéticamente y su uso en el tratamiento de deficiencia de la otc. (divisional solicitud 201602235)
JP2019513393A5 (https=)
AR129651A2 (es) Optimización de anticuerpos que se fijan al gen de activación de linfocitos 3 (lag-3) y sus usos
JP2017538401A5 (https=)
PH12020551744A1 (en) Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues
NZ763018A (en) Adeno-associated virus variant capsids and methods of use thereof
JP2021536244A5 (https=)
JP2019513399A5 (https=)
RU2016123086A (ru) Способы и композиции для лечения болезни хантингтона
JP2014512171A5 (https=)
EA201991911A1 (ru) Способы и композиции для переноса генов по сосудистой сети
JP2018520997A5 (https=)
WO2015158749A3 (de) Viraler vektor für den zielgerichteten gentransfer in gehirn und rückenmark
JP2015500002A5 (https=)
HRP20250541T1 (hr) Isporuka mikro-distrofina s adeno-povezanim virusnim vektorom za liječenje mišićne distrofije
MX367100B (es) Composiciones del vector aav y metodos para su transferencia genetica a celulas, organos y tejidos.
EP4219725A3 (en) Altering gene expression in modified t cells and uses thereof
EA201492048A1 (ru) Полипептиды, связывающиеся с хемокиновым рецептором
UA107921C2 (en) Variants of polypeptide of receptor ivr activin and their use
JP2019523648A5 (https=)
EA202092589A3 (ru) Cxcr2-связывающие полипептиды
JP2015526391A5 (https=)
JP2018531624A5 (https=)
JP2017532343A5 (https=)